人乳头状瘤病毒感染与肺癌预后相关性的Meta分析

doi:10.11904/j.issn.1002-3070.2018.06.008

实用肿瘤学杂志 ›› 2018, Vol. 32 ›› Issue (6): 520-526.doi: 10.11904/j.issn.1002-3070.2018.06.008

人乳头状瘤病毒感染与肺癌预后相关性的Meta分析

王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维

国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院(北京 100021)

收稿日期:2018-10-16 出版日期:2018-12-28 发布日期:2018-12-27
通讯作者: 谭锋维, E-mail:tanfengwei@126.com
作者简介:王亚龙, 男, (1993-), 博士研究生, 从事胸部肿瘤临床和基础的研究。
基金资助:
国家重点研发计划(编号:2018YFC1315000/2018YFC1315003);国家自然科学基金(编号:8187102812, 81402300);北京市科技计划(编号:Z181100001718212, Z161100000116044);中国医学科学院医学与健康科技创新工程(编号:2017-I2M-1-005);中国医学科学院肿瘤医院院所科研课题(编号:LC2017A01, LC2017D01);中央保健专项资金(编号:W2017BJ39);北京协和医学院协和青年科研基金(编号:2017320013);国家科技支撑计划(编号:2015BAI12B08);首都临床特色应用研究(编号:Z151100004015188)

Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis

WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Received:2018-10-16 Online:2018-12-28 Published:2018-12-27

摘要/Abstract

摘要： 目的采用Meta分析方法探索人乳头瘤状病毒(Human papillomavirus, HPV)感染与肺癌预后的相关性。方法利用主题词与自由词结合的方式, 检索PubMed、Embase和Cochrane文献数据库。截至2018年10月, 共检索获得123篇相关文献。根据纳入和排除标准筛选文献后, 摘录研究基本信息、HPV检测方法、肺癌患者、风险比(Hazard ratio, HR)值和95%可信区间(Confidence interval, CI)等指标。利用随机效应模型的Meta分析, 评价HPV感染与肺癌患者预后相关性。利用Q检验和I²统计量评价异质性, 利用Egger's和Begg's法检验发表偏倚。结果本研究最终纳入文献11篇(亚洲地区9篇, 欧洲地区和美国2篇), 纳入肺癌患者1501例。使用随机效应模型的Meta分析结果显示, HPV感染与肺癌预后无统计学关联, 合并HR=0.90, 95% CI:0.71~1.13。针对肺癌病理亚型进行分层分析, 结果提示, HPV感染肺腺癌患者的预后明显优于无HPV感染肺腺癌患者, 合并HR=0.65, 95% CI:0.49~0.85。通过依次剔除纳入的研究, 进行敏感性分析, 结果无统计学变化。Egger's检验(P=0.708)和Begg's检验(P=0.784)的结果提示, 本研究不存在发表偏倚。结论 HPV感染与肺腺癌患者预后可能相关, 未来仍需更多基础和临床研究进一步探索HPV感染和肺腺癌的关联及其背后的机理机制。

关键词: 人乳头瘤状病毒, 肺肿瘤, 腺癌, 预后, Meta分析

Abstract: Objective The Objective of this study was to explore the association between human papillomavirus(HPV)and prognosis of lung cancer by meta-analysis. Methods The PubMed, Embase and Cochrane literature databases studies were searched using a combination of subject terms and free words.As of October 2018, a total of 123 related documents were obtained.After screening the literature according to inclusion and exclusion criteria, the basic information of the study, HPV detection methods, lung cancer patients, hazard ratio(HR)values and 95% confidence interval(CI)were extracted from each study.The meta-analysis of random effects models was used to evaluate the correlation between HPV infection and prognosis in patients with lung cancer.Heterogeneity was assessed using the Q test and I² statistics, and publication bias was tested using Egger's linear regression test and Begg's rank correlation test. Results The study finally included 11 articles(9 in Asia, 2 in Europe and US), and 1439 patients with lung cancer.Meta-analysis using a random-effects model showed no significant association between HPV infection and prognosis of lung cancer(HR=0.90, 95% CI:0.71~1.13).A stratified analysis of lung cancer pathological subtypes showed that the prognosis of patients with HPV-infected lung adenocarcinoma was significantly better than that in patients without HPV-infected lung adenocarcinoma(HR=0.65, 95% CI:0.49~0.85).Sensitivity analysis was performed by sequentially removing the included studies, and the results were not statistically significant.The results of Egger's test(P=0.708)and Begg's test(P=0.784)suggest that there is no publication bias in this study. Conclusion HPV infection may be related to the prognostic of patients with lung adenocarcinoma.More basic and clinical studies are needed to further explore the association between HPV infection and lung adenocarcinoma as well as the corresponding mechanisms in the future.

Key words: Human papillomavirus virus, Lung neoplasms, Adenocarcinoma, Prognosis, Meta-analysis

中图分类号:

R734.2

王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.

WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.

参考文献

1 Ferlay J, Soerjomataram I, Dikshit R, et al.Cancer incidence and mortality worldwide:Sources, methods and major patterns in globocan 2012[J].Int J Cancer, 2015, 136(5):359-386.
2 Chen W, Zheng R, Baade PD, et al.Cancer statistics in china, 2015[J].CA Cancer J Clin, 2016, 66(2):115-132.
3 陈万青, 孙可欣, 郑荣寿, 等.2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤, 2018, 27(1):1-14.
4 Zeng H, Zheng R, Guo Y, et al.Cancer survival in china, 2003-2005:A population-based study[J].Int J Cancer, 2015, 136(8):1921-1930.
5 Lachmann P.Cancer survival in australia, canada, denmark, norway, sweden, and the uk[J].Lancet, 2011, 377(9772):1149-1149.
6 Detterbeck FC, Boffa DJ, Kim AW, et al.The 8(th)edition lung cancer stage classification[J].Chest, 2016, 151(1):193.
7 Hang D, Jia M, Ma H, et al.Independent prognostic role of human papillomavirus genotype in cervical cancer[J].BMC Infect Dis, 2017, 17(1):391.
8 Kong CS, Narasimhan B, Cao H, et al.The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas[J].Int J Radiat Oncol Biol Phys, 2009, 74(2):553-561.
9 Parmar MK, Torri V, Stewart L.Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints [M].Stat Med, 1998, 17(24):2815-2834.
10 Tierney JF, Stewart LA, Ghersi D, et al.Practical methods for incorporating summary time-to-event data into meta-analysis[J].Trials, 2007, 8(1):16.
11 Iwamasa T, Miyagi J, Tsuhako K, et al.Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung[J].Pathol Res Pract, 2000, 196(4):209-218.
12 Miyagi J, Kinjo T, Tsuhako K, et al.Extremely high langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung[J].Histopathology, 2001, 38(4):355-367.
13 Hsu NY, Cheng YW, Chan IP, et al.Association between expression of human papillomavirus 16/18 e6 oncoprotein and survival in patients with stage I non-small cell lung cancer[J].Oncol Rep, 2009, 21(1):81-87.
14 Wu DW, Tsai LH, Chen PM, et al.Loss of timp-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in hpv-infected non-small cell lung cancer[J].Am J Pathol, 2012, 181(5):1796-1806.
15 Chen SP, Hsu NY, Wu JY, et al.Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients[J].Ann Thorac Surg, 2013, 95(4):1196-1203.
16 Anantharaman D, Gheit T, Waterboer T, et al.No causal association identified for human papillomavirus infections in lung cancer[J].Cancer Res, 2014, 74(13):3525-3534.
17 Chen PM, Cheng YW, Wang YC, et al.Up-regulation of foxm1 by e6 oncoprotein through the mzf1/nkx2-1 axis is required for human papillomavirus-associated tumorigenesis[J].Neoplasia, 2014, 16(11):961-971.
18 Wang JL, Fang CL, Wang M, et al.Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma[J].Int J Cancer, 2014, 134(1):65-71.
19 Li M, Deng F, Qian LT, et al.Association between human papillomavirus and egfr mutations in advanced lung adenocarcinoma[J].Oncol Lett, 2016, 12(3):1953-1958.
20 Li M, Zhang XL, Deng F, et al.Involvement of tp53 and tp16 expression in human papillomavirus-associated non-small cell lung cancer[J].Oncol Lett, 2016, 12(5):3330-3336.
21 Robinson LA, Jaing CJ, Pierce Campbell C, et al.Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung[J].Br J Cancer, 2016, 115(4):497-504.
22 Thunnissen E, Oord KVD, Bakker MD.Prognostic and predictive biomarkers in lung cancer.A review[J].Virchows Archiv, 2014, 464(3):347-358.
23 柯立, 徐美青, 魏大中, 等.非小细胞肺癌中s100a2和p53蛋白的表达[J].安徽医科大学学报, 2010, 45(4):558-561.
24 Reimers N, Kasper HU, Weissenborn SJ, et al.Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer[J].Int J Cancer, 2007, 120(8):1731-1738.
25 Wittekindt C, Gultekin E, Weissenborn SJ, et al.Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival[J].Adv Otorhinolaryngol, 2005, 62:72-80.

[1]	王晓雅,肖斌,廖扬,唐荣芝,孙朝晖,李林海. CXCR家族蛋白在不同乳腺癌亚型中的表达及临床预后分析[J]. 实用肿瘤学杂志, 2019, 33(3): 206-210.
[2]	李烁,张楠楠,李亮亮,龙志平,尹慧慧,赵亚双,王帆. 外周血白细胞PDE4C基因甲基化及环境因素交互作用与乳腺癌发病的关系[J]. 实用肿瘤学杂志, 2019, 33(3): 233-238.
[3]	李嘉琪,栾瑾微,张,玉,李香兰. 763例三阴性乳腺癌临床病理特征及复发、转移影响因素分析[J]. 实用肿瘤学杂志, 2019, 33(3): 244-249.
[4]	李珊,赵春波,乔文波. 术中放疗在胰腺癌中的应用进展[J]. 实用肿瘤学杂志, 2019, 33(3): 280-283.
[5]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[6]	陈艳波, 孔德嘉, 张金锋, 马志刚. 乳腺癌患者CYP2D6基因多态性与他莫昔芬代谢相关性研究[J]. 实用肿瘤学杂志, 2019, 33(2): 110-114.
[7]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[8]	石小康, 丁佑铭, 汪斌, 余斌, 徐雨. UBE2T在原发性肝癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(2): 128-133.
[9]	孙江宏, 郝明珠, 姜丹, 国飞, 李晓梅. 乳腺炎、良性增生及乳腺癌FFDM鉴别诊断思路[J]. 实用肿瘤学杂志, 2019, 33(2): 139-141.
[10]	马志杰, 王帆, 赵亚双. 乳腺癌化疗患者生存质量及影响因素分析[J]. 实用肿瘤学杂志, 2019, 33(2): 149-154.
[11]	卢姣云, 张清媛. 实验室标志物在弥漫大B细胞淋巴瘤预后中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 183-187.
[12]	罗干, 易超, 依马木买买提江·阿布拉, 徐林, 尹继炜, 丁伟. Notch信号通路在胰腺癌中的表达及其作用研究[J]. 实用肿瘤学杂志, 2019, 33(1): 1-7.
[13]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[14]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[15]	马健力, 张明辉, 姬宏飞, 徐向英. PD-L1蛋白与CD8⁺TILs联合检测在可切除肺腺癌预后评估中的临床意义[J]. 实用肿瘤学杂志, 2019, 33(1): 40-46.

人乳头状瘤病毒感染与肺癌预后相关性的Meta分析

Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价